19 Devices and Treatment Options for Axillary Hyperhidrosis

Cameron Rokhsar and Austin Lee

Summary

Primary hyperhidrosis, or uncontrollable sweating, is a condition that affects the social and psychological well-being of millions of people worldwide. It can present in several focal, eccrine-dense areas, with the axillae being one of the most common. Following diagnosis and an assessment of severity, patients can choose from several treatment options for axillary hyperhidrosis. These include topical, injectable, and systemic pharmacological treatments, and devices such as lasers and microwave energy delivery systems. We explain here the effectiveness and techniques involved in these treatment options, postoperative care, and management of potential complications.

Schlüsselwörter

primary hyperhidrosis - axillae - pharmacological treatment - topical - injectable - systemic - devices - lasers - microwaves

• 1 Walling HW. Clinical differentiation of primary from secondary hyperhidrosis.. J Am Acad Dermatol 2011; 64 (4) 690-695 PubMed (PMID: 21334095)

• 2 Schlereth T, Dieterich M, Birklein F. Hyperhidrosis: causes and treatment of enhanced sweating.. Dtsch Arztebl Int 2009; 106 (3) 32-37 PubMed (PMID: 19564960)

• 3 Miller JL. Diseases of the eccrine and apocrine sweat glands. In: Bolognia JL, Jorizzo JL, Schaffer JV, eds. Dermatology. 3rd ed. Philadelphia, PA: Elsevier; 2012

• 4 Hornberger J, Grimes K, Naumann M, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis.. J Am Acad Dermatol 2004; 51 (2) 274-286 PubMed (PMID: 15280848)

• 5 Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.. J Am Acad Dermatol 2004; 51 (2) 241-248 PubMed (PMID: 15280843)

• 6 Ricchetti-Masterson K, Symons JM, Aldridge M et al. Epidemiology of hyperhidrosis in 2 population-based health care databases.. J Am Acad Dermatol 2018; 78 (2) 358-362 PubMed (PMID: 28993234)

• 7 Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schaefer I. Prevalence and disease burden of hyperhidrosis in the adult population.. Dermatology 2013; 227 (1) 10-13 PubMed (PMID: 23988406)

• 8 Liu Y, Bahar R, Kalia S et al. Hyperhidrosis prevalence and demographical characteristics in dermatology outpatients in Shanghai and Vancouver.. PLoS One 2016; 11 (4) e0153719 PubMed (PMID: 27105064)

• 9 Fujimoto T, Kawahara K, Yokozeki H. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis.. J Dermatol 2013; 40 (11) 886-890 PubMed (PMID: 24106874)

• 10 Kowalski JW, Eadie N, Dagget S, Lai P. Validity and reliability of the Hyperhidrosis Disease Severity Scale (HDSS).. J Am Acad Dermatol 2004; 50 (3) 51 (PMID: NOT_FOUND)

• 11 Stefaniak TJ, Proczko M. Gravimetry in sweating assessment in primary hyperhidrosis and healthy individuals.. Clin Auton Res 2013; 23 (4) 197-200 PubMed (PMID: 23761115)

• 12 Pariser DM, Ballard A. Topical therapies in hyperhidrosis care.. Dermatol Clin 2014; 32 (4) 485-490 PubMed (PMID: 25152341)

• 13 Hölzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution.. Br J Dermatol 1984; 110 (4) 399-403 PubMed (PMID: 6712884)

• 14 Hölzle E. Topical pharmacological treatment.. Curr Probl Dermatol 2002; 30: 30-43 PubMed (PMID: 12471696)

• 15 Glaser DA, Hebert AA, Nast A et al. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.. J Am Acad Dermatol 2019; 80 (1) 128-138.e2 PubMed (PMID: 30003988)

• 16 Doft MA, Hardy KL, Ascherman JA. Treatment of hyperhidrosis with botulinum toxin.. Aesthet Surg J 2012; 32 (2) 238-244 PubMed (PMID: 22328694)

• 17 Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, . Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.. J Am Acad Dermatol 2007; 56 (4) 604-611 PubMed (PMID: 17306417)

• 18 Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.. BMJ 2001; 323 (7313) 596-599 PubMed (PMID: 11557704)

• 19 Walling HW. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.. J Am Acad Dermatol 2012; 66 (3) 387-392 PubMed (PMID: 21820204)

• 20 Glaser DA. Oral medications.. Dermatol Clin 2014; 32 (4) 527-532 PubMed (PMID: 25152346)

• 21 Johnson JE, O’Shaughnessy KF, Kim S. Microwave thermolysis of sweat glands.. Lasers Surg Med 2012; 44 (1) 20-25 PubMed (PMID: 22127730)

• 22 Glaser DA, Coleman III WP, Fan LK et al. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study.. Dermatol Surg 2012; 38 (2) 185-191 PubMed (PMID: 22289389)

• 23 Nestor MS, Park H. Safety and efficacy of micro-focused ultrasound plus visualization for the treatment of axillary hyperhidrosis.. J Clin Aesthet Dermatol 2014; 7 (4) 14-21 PubMed (PMID: 24765226)

• 24 Leclère FM, Moreno-Moraga J, Alcolea JM et al. Efficacy and safety of laser therapy on axillary hyperhidrosis after one year follow-up: a randomized blinded controlled trial.. Lasers Surg Med 2015; 47 (2) 173-179 PubMed (PMID: 25663083)

• 25 Goldman A, Wollina U. Subdermal Nd-YAG laser for axillary hyperhidrosis.. Dermatol Surg 2008; 34 (6) 756-762 PubMed (PMID: 18318722)

• 26 Bechara FG, Georgas D, Sand M et al. Effects of a long-pulsed 800-nm diode laser on axillary hyperhidrosis: a randomized controlled half-side comparison study.. Dermatol Surg 2012; 38 (5) 736-740 PubMed (PMID: 22273498)

• 27 Aydin F, Pancar GS, Senturk N et al. Axillary hair removal with 1064-nm Nd:YAG laser increases sweat production.. Clin Exp Dermatol 2010; 35 (6) 588-592 PubMed (PMID: 19874331)

• 28 Letada PR, Landers JT, Uebelhoer NS, Shumaker PR. Treatment of focal axillary hyperhidrosis using a long-pulsed Nd:YAG 1064 nm laser at hair reduction settings.. J Drugs Dermatol 2012; 11 (1) 59-63 PubMed (PMID: 22206078)

• 29 Kim M, Shin JY, Lee J, Kim JY, Oh SH. Efficacy of fractional microneedle radiofrequency device in the treatment of primary axillary hyperhidrosis: a pilot study.. Dermatology 2013; 227 (3) 243-249 PubMed (PMID: 24107595)

• 30 Fatemi Naeini F, Abtahi-Naeini B, Pourazizi M, Nilforoushzadeh MA, Mirmohammadkhani M. Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: a sham control study.. Australas J Dermatol 2015; 56 (4) 279-284 PubMed (PMID: 25496000)

• 31 Abtahi-Naeini B, Naeini FF, Saffaei A et al. Treatment of primary axillary hyperhidrosis by fractional microneedle radiofrequency: is it still effective after long-term follow-up?. Indian J Dermatol 2016; 61 (2) 234 PubMed (PMID: 27057039)

• 32 Schick CH, Grallath T, Schick KS, Hashmonai M. Radiofrequency thermotherapy for treating axillary hyperhidrosis.. Dermatol Surg 2016; 42 (5) 624-630 PubMed (PMID: 27110892)